Tilray Brands (TLRY)
(Delayed Data from NSDQ)
$1.82 USD
-0.03 (-1.62%)
Updated May 28, 2024 04:00 PM ET
After-Market: $1.81 -0.01 (-0.55%) 7:58 PM ET
3-Hold of 5 3
F Value D Growth B Momentum F VGM
Brokerage Reports
0 items in cart
Tilray Brands, Inc. [TLRY]
Reports for Purchase
Showing records 121 - 140 ( 219 total )
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Receives Final GMP for EU and Closing Acquired Greenhouse in Ontario
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
1Q20 Mixed, Sales Up with Impairment Charges and Cost Cuts
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Assessing Key Liquidity Concerns for the Cannabis Industry
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Coronavirus (COVID-19) Unknowns and Impact on the Supply Chain
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
Company: Tilray Brands, Inc.
Industry: Medical - Drugs
4Q19 Results Miss, Much the Same Market Headwinds
Provider: Roth Capital Partners, Inc.
Analyst: FORTUNE S